Underestimation of renal artery lumen diameter by computed tomography has consequences for the assessment of patient eligibility for renal denervation

Keisuke Okamura,Masatoshi Matsushima,Shunsuke Satou,Akane Ishiya,Hideaki Shimada,Tetsu Okuda,Ichiro Imamura,Hidenori Urata,Shin-ichiro Miura

DOI: https://doi.org/10.1038/s41440-024-01718-3

2024-05-18

Hypertension Research

Abstract:Recently, measuring lumen diameter (LD) of renal artery (RA) became relevant with the introduction of renal denervation (RDN) as a treatment for hypertension. This LD is one of the anatomical inclusion criteria in trials on RDN. For example, the inclusion criterion in the REQUIRE study is a LD of main RA ≥ 4 mm and <8 mm. Cases with an accessory RA with an LD ≥ 2 mm and <4 mm are excluded [1, 2] because of the variation of devices. Our findings in the case presented here indicate that patients who are eligible for RDN might be excluded if decisions are based only on CTA. Similar cases are often seen. Because the number of eligible cases for RDN trial is small [3], it would be disappointing if cases were excluded because CTA erroneously identified anatomical problems. In the RADIANCE-HTN SOLO study, cases excluded on the basis of preoperative images accounted for as many as 17% of all exclusions [4]. This number might have included many patients who were actually eligible for the study.

peripheral vascular disease